|
S.No |
Applications |
Resource |
|
1 |
Tumor Hypoxia Imaging with [F-18] Fluoromisonidazole Positron Emission
Tomography in Head and Neck
Cancer |
Joseph G. Rajendran, et al.Clin
Cancer Res., 2006, 12, 5435. |
|
2 |
Assessment of hypoxia in esophageal carcinomas using 18F-MISO PET |
Ingo Brink, et al. J Nucl
Med., 2008, 49 (Supplement 1), 113P |
|
3 |
Hypoxia positron emission tomography imaging with 18F-fluoromisonidazole |
Lee ST, et al. Sem Nucl Med., 2007, 37, 451. |
|
4 |
Quantifying regional hypoxia in human tumors with positron emission
tomography of [18F] fluoromisonidazole: a pretherapy study of 37
patients |
Rasey JS, et al. Int J Radiat Oncol Biol Phys., 1996, 36, 417. |
|
5 |
Regional hypoxia in
glioblastoma multiforme quantified with [18F]fluoromisonidazole
positron emission tomography before radiotherapy: correlation with
time to progression and survival. |
Spence et al. Clin Cancer Res., 2008, 14, 2623. |
|
6 |
pO polarography,
contrast enhanced color duplex sonography(CDS), [18F]
fluoromisonidazole and [18F] fluorodeoxyglucose positron emission
tomography: validated methods for the evaluation of
therapy-relevant tumor oxygenation or only bricks in the puzzle
of tumor hypoxia? |
Bernd Gagel, et al. BMC Cancer., 2007, 7 113. |